-
-
-
-
-
-
-
Collegium to acquire AZSTARYS from Corium for $650 million
-
-
-
-
-
-
-
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
-
-
-
-
-
-
-
Collegium Pharma (COLL) Appoints Nancy S. Lurker to its Board
-
-
-
-
-
-
-
Piper Sandler Reiterates Neutral Rating on Collegium Pharmaceutical (COLL)
-
-
-
-
-
-
-
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
-
-
-
-
-
-
-
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
-
-
-
-
-
-
-
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
-
1,179,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

